Tenax Therapeutics (TENX) Non-Current Assets (2011 - 2024)
Tenax Therapeutics (TENX) reported Non-Current Assets of $1117.0 for Q3 2024, down 80.82% on a YoY basis from $5823.0 in Q4 2023, and little changed sequentially from $1117.0 in Q2 2024.
Tenax Therapeutics (TENX) Non-Current Assets (2011 - 2024) Analysis & Trends
Tenax Therapeutics (TENX) has 13 years of Non-Current Assets data on file, last reported at $1117.0 in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Assets fell 80.82% year-over-year to $1117.0; the trailing twelve-month figure through Jun 2025 stood at $1117.0 (down 87.67% YoY), and the FY2023 full-year result was $1000.0, down 99.49% from the prior year.
- Non-Current Assets held at $1117.0 in Q3 2024, from $1117.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $352954.0 in Q2 2021 to a low of $1000.0 in Q4 2023.
- A 5-year average of $130338.9 and a median of $99181.0 in 2020 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 556.27% in 2022 and sank 99.49% in 2023, its largest moves.
- Tracing TENX's Non-Current Assets over 5 years: stood at $73185.0 in 2020, then surged by 314.34% to $303235.0 in 2021, then sank by 35.28% to $196244.0 in 2022, then slumped by 99.49% to $1000.0 in 2023, then advanced by 11.7% to $1117.0 in 2024.
- Business Quant data shows TENX's Non-Current Assets at $1117.0 in Q3 2024, $1117.0 in Q2 2024, and $1117.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1,117.00 |
| Jun 30, 2024 | 1,117.00 |
| Mar 31, 2024 | 1,117.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 5,823.00 |
| Jun 30, 2023 | 6,792.00 |
| Mar 31, 2023 | 6,749.00 |
| Dec 31, 2022 | 196,244.00 |
| Sep 30, 2022 | 225,427.00 |
| Jun 30, 2022 | 253,941.00 |
| Mar 31, 2022 | 281,948.00 |
| Dec 31, 2021 | 303,235.00 |
| Sep 30, 2021 | 328,367.00 |
| Jun 30, 2021 | 352,954.00 |
| Mar 31, 2021 | 42,962.00 |
| Dec 31, 2020 | 73,185.00 |
| Sep 30, 2020 | 99,181.00 |
| Jun 30, 2020 | 138,792.00 |
| Mar 31, 2020 | 156,488.00 |
| Dec 31, 2019 | 184,442.00 |